Literature DB >> 20861318

Homomultimerization of the reovirus p14 fusion-associated small transmembrane protein during transit through the ER-Golgi complex secretory pathway.

Jennifer A Corcoran1, Eileen K Clancy, Roy Duncan.   

Abstract

The reovirus fusion-associated small transmembrane (FAST) proteins are the smallest known viral membrane-fusion proteins. How these diminutive fusogens mediate cell-cell fusion and syncytium formation is unclear. Ongoing efforts are aimed at defining the roles of the FAST protein ecto-, endo- and transmembrane domains in the membrane-fusion reaction. We now provide direct evidence for homomultimer formation by the FAST proteins by using an anti-haemagglutinin (HA) mAb to co-precipitate the untagged p14 FAST protein from cells co-transfected with HA-tagged p14. Disrupting the intracellular endoplasmic reticulum-Golgi complex vesicle transport pathway prevented p14 homomultimer formation, while lower pH disrupted p14 multimers. The p14 endodomain or transmembrane domains are not required for multimer formation, which, along with the pH sensitivity and the distribution of histidine residues, suggests the 36 aa p14 ectodomain is a multimerization motif.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861318     DOI: 10.1099/vir.0.026013-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Evolutionarily related small viral fusogens hijack distinct but modular actin nucleation pathways to drive cell-cell fusion.

Authors:  Ka Man Carmen Chan; Ashley L Arthur; Johannes Morstein; Meiyan Jin; Abrar Bhat; Dörte Schlesinger; Sungmin Son; Donté A Stevens; David G Drubin; Daniel A Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

2.  Efficient reovirus- and measles virus-mediated pore expansion during syncytium formation is dependent on annexin A1 and intracellular calcium.

Authors:  Marta Ciechonska; Tim Key; Roy Duncan
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

Review 3.  Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.

Authors:  Joshua Del Papa; Ryan G Clarkin; Robin J Parks
Journal:  Cancer Gene Ther       Date:  2020-07-01       Impact factor: 5.987

4.  Golgi complex-plasma membrane trafficking directed by an autonomous, tribasic Golgi export signal.

Authors:  Hirendrasinh B Parmar; Christopher Barry; Fuiboon Kai; Roy Duncan
Journal:  Mol Biol Cell       Date:  2014-01-22       Impact factor: 4.138

5.  Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer.

Authors:  Carmen M Wong; Kathy L Poulin; Grace Tong; Carin Christou; Michael A Kennedy; Theresa Falls; John C Bell; Robin J Parks
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.

Authors:  C M Wong; L A Nash; J Del Papa; K L Poulin; T Falls; J C Bell; R J Parks
Journal:  Cancer Gene Ther       Date:  2016-10-14       Impact factor: 5.987

7.  Cell-cell fusion induced by reovirus FAST proteins enhances replication and pathogenicity of non-enveloped dsRNA viruses.

Authors:  Yuta Kanai; Takahiro Kawagishi; Yusuke Sakai; Ryotaro Nouda; Masayuki Shimojima; Masayuki Saijo; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  PLoS Pathog       Date:  2019-04-25       Impact factor: 6.823

Review 8.  Structural Insights into Membrane Fusion Mediated by Convergent Small Fusogens.

Authors:  Yiming Yang; Nandini Nagarajan Margam
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

9.  A novel tribasic Golgi export signal directs cargo protein interaction with activated Rab11 and AP-1-dependent Golgi-plasma membrane trafficking.

Authors:  Hirendrasinh B Parmar; Roy Duncan
Journal:  Mol Biol Cell       Date:  2016-03-03       Impact factor: 4.138

10.  Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.

Authors:  Fabrice Le Boeuf; Simon Gebremeskel; Nichole McMullen; Han He; Anna L Greenshields; David W Hoskin; John C Bell; Brent Johnston; Chungen Pan; Roy Duncan
Journal:  Mol Ther Oncolytics       Date:  2017-08-04       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.